CancerLivER: Biomarker Card

Biomarker Card: Comprehensive information about a biomarker


Biomarker ID 2351
Detailed information
CancerLivER ID2351
Biomarker CYP3A5P2
Biomarker Name/Symbol (given in Publication)CYP3A5P2
BiomoleculeRNAs
SubjectHuman
Degree of ValidityDifferentially expressed in HCCs with PVI in comparison with HCCs without PVI; but not validated on independent dataset
Experimental ConditionHCC with PVI v/s HCC without PVI
Cancer typeHepatocellular carcinoma
RegulationDownregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.21)
Level of significance p < 0.05
SourceTissue
PMID17088983
Type of BiomarkerPrognostic
PathwayDetoxification system
Cohort14 HCCs with PVI and 21 HCCs without PVI.
SensitivityNA
SpecificityNA
AccuracyNA
AUCNA
DiseaseHCV associated HCC
Year of Publication2006
Clinical trialNO
Clinical trial (NCT Number)NA

         Raghava's group    CancerCSP    CancerSPP    CancerPDF    CancerTSP    CancerLSP    HCCPred   

Scroll to Top